Renflexis for Crohn's Disease User Reviews
- Anonymous
- Taken for less than 1 month
- June 21, 2023
"This medication totally debilitated me. It’s a generic drug that should be taken off the market."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
Learn more about Crohn's Disease
Symptoms and treatments
Medicine.com guides (external)
More about Renflexis (infliximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
- En español
Patient resources
- Renflexis drug information
- Renflexis (Infliximab Intravenous) (Advanced Reading)
- Renflexis (Infliximab-abda Intravenous) (Advanced Reading)
Other brands
Remicade, Inflectra, Avsola, Zymfentra, Ixifi
Professional resources
Other brands
Remicade, Inflectra, Avsola, Zymfentra
"I started with Remicade/Inflectra in 2019 when my Crohn's disease became super activated in graduate school. Both of those helped. I was switched by my provider to Renflexis this past September due to cost, and my last two infusions were with Renflexis. I have noticed an improvement over Inflectra. Bowel movement frequency has decreased, and the looseness of stools has improved - and I have a very short gut due to two bowel excisions and resections. I'm pretty excited about this improvement. I was worried initially and reassured that it is biosimilar. It may be, but whatever difference Renflexis has, it's working better for me!"